Doxycychne may reduce the incidence of aneurysms in haemodialysis vascular accesses

被引:8
作者
Diskin, C [1 ]
Stokes, TJ [1 ]
Dansby, LM [1 ]
Radcliff, L [1 ]
Thomas, LR [1 ]
机构
[1] Auburn Univ, HNDT, Opelika, AL 36801 USA
关键词
aneurysms; antibiotics; haemodialysis; medications; vascular access;
D O I
10.1093/ndt/gfh694
中图分类号
R3 [基础医学]; R4 [临床医学];
学科分类号
1001 ; 1002 ; 100602 ;
摘要
Background. Doxycycline can prevent aortic aneurysms through the inhibition of enzymes that degrade vessel walls. We investigated whether haemodialysis patients who had received one or more courses of doxycycline were at less risk for aneurysms in their vascular accesses than those who had received other antibiotics. Methods. Three hundred and eight patients undergoing chronic maintenance hemodialysis were evaluated for aneurysm formation after exposure to doxycycline or another antibiotic. Conditional forward logistical analysis using Cox proportional hazards test (SPSS) was performed to determine the potential significance of differences of aneurysm formation between the two groups. Results. Patients who had received doxycycline appeared to be at lower risk than the control group, but the effect was most obvious in those patients with synthetic grafts. Conclusions. Doxycycline may have the ability to reduce aneurysm formation in haemodialysis vascular accesses and a large prospective study is warranted.
引用
收藏
页码:959 / 961
页数:3
相关论文
共 11 条
[1]   Prolonged administration of doxycycline in patients with small asymptomatic abdominal aortic aneurysms: Report of a prospective (Phase II) multicenter study [J].
Baxter, BT ;
Pearce, WH ;
Waltke, EA ;
Littooy, FN ;
Hallett, JW ;
Kent, KC ;
Upchurch, GR ;
Chaikof, EL ;
Mills, JL ;
Fleckten, B ;
Longo, GM ;
Lee, JK ;
Thompson, RW .
JOURNAL OF VASCULAR SURGERY, 2002, 36 (01) :1-12
[2]   Clinical and biochemical results of the metalloproteinase inhibition with subantimicrobial doses of doxycycline to prevent acute coronary syndromes (MIDAS) pilot trial [J].
Brown, DL ;
Desai, KK ;
Vakili, BA ;
Nouneh, C ;
Lee, HM ;
Golub, LM .
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY, 2004, 24 (04) :733-738
[3]   PHARMACOLOGICAL INTERVENTION TO PREVENT HEMODIALYSIS VASCULAR ACCESS THROMBOSIS [J].
DISKIN, CJ ;
STOKES, TJ ;
PENNELL, AT .
NEPHRON, 1993, 64 (01) :1-26
[4]   An analysis of the effect of routine medications on hemodialysis vascular access survival [J].
Diskin, CJ ;
Stokes, TJ ;
Thomas, SG ;
Ravis, W ;
Lock, S ;
Thomas, J ;
Panus, LW ;
Dansby, L ;
Carter, T .
NEPHRON, 1998, 78 (03) :365-368
[5]   A nonantibiotic chemically modified tetracycline (CMT-3) inhibits intimal thickening [J].
Islam, MM ;
Franco, CD ;
Courtman, DW ;
Bendeck, MP .
AMERICAN JOURNAL OF PATHOLOGY, 2003, 163 (04) :1557-1566
[6]   Doxycycline treatment in a model of early abdominal aortic aneurysm [J].
Kaito, K ;
Urayama, H ;
Watanabe, G .
SURGERY TODAY, 2003, 33 (06) :426-433
[7]   Subantimicrobial dose doxycycline efficacy as a matrix metalloproteinase inhibitor in chronic periodontitis patients is enhanced when combined with a non-steroidal anti-inflammatory drug [J].
Lee, HM ;
Ciancio, SG ;
Tilter, G ;
Ryan, ME ;
Komaroff, E ;
Golub, LM .
JOURNAL OF PERIODONTOLOGY, 2004, 75 (03) :453-463
[8]   STRUCTURAL-ANALYSIS OF THE CATALYTIC DOMAIN OF HUMAN FIBROBLAST COLLAGENASE [J].
LOVEJOY, B ;
CLEASBY, A ;
HASSELL, AM ;
LUTHER, MA ;
WEIGL, D ;
MCGEEHAN, G ;
LAMBERT, MH ;
JORDAN, SR .
INHIBITION OF MATRIX METALLOPROTEINASES: THERAPEUTIC POTENTIAL, 1994, 732 :375-378
[9]  
MOORING M, 2001, J VASC SURG, V34, P606
[10]   Association between vascular access failure and the use of specific drugs: The Dialysis Outcomes and Practice Patterns Study (DOPPS) [J].
Saran, R ;
Dykstra, DM ;
Wolfe, RA ;
Gillespie, B ;
Held, PJ ;
Young, EW .
AMERICAN JOURNAL OF KIDNEY DISEASES, 2002, 40 (06) :1255-1263